Endovascular Stents: Preliminary Clinical Results and Future Developments

作者: Peter P. T. De Jaegere , Pim J. De Feyter , Willem J. Van Der Giessen , Patrick W. Serruys

DOI: 10.1002/CLC.4960160503

关键词:

摘要: Summary: At present, there is an exponential use of new interventional techniques whose proper role and value have not yet been defined. The intracoronary stent just one example. There no doubt that stents can be implanted with a high technical success rate associated highly predictable immediate angiographic results they appear to superior all other techniques. However, the intrinsic thrombogenicity devices cmntly available for clinical warrants vigorous anticoagulation, exposing patient either risk (sub)acute thrombosis or hemorrhage vascular complications. It remains determined whether implantation will reduce incidence restenosis this in improved long-term event symptom-free survival. Experimental studies indicate thrombogenic nature may controlled by coating struts endothelial cells polymers. With respect restem sis, it evident as long mechanical injury applied vessel wall, wall respond neointimal thickening. has potential control tissue response serving carrier local antiproliferative drug delivery eventually genetic manipulation. intensive research which now going on Combination experimental animal data, human postmortem pathologic observations, yielding clear insights future directions address these issues.

参考文章(77)
James A. Hearn, Spencer B. King, John S. Douglas, Gary S. Roubin, Restenosis after Gianturco-Roubin Stent Placement for Acute Closure Springer Netherlands. pp. 207- 214 ,(1992) , 10.1007/978-94-011-2650-2_12
David L. Fischman, Michael P. Savage, Stephen G. Ellis, Richard A. Schatz, Martin B. Leon, Donald Baim, Sheldon Goldberg, Restenosis after Palmaz-Schatz™ Stent Implantation Springer Netherlands. pp. 191- 205 ,(1992) , 10.1007/978-94-011-2650-2_11
M F Shiu, N P Silverton, D Oakley, D Cumberland, Acute coronary occlusion during percutaneous transluminal coronary angioplasty. Heart. ,vol. 54, pp. 129- 133 ,(1985) , 10.1136/HRT.54.2.129
H.M.M. van Beusekom, P.W. Serruys, W.J. van der Giessen, B.H. Strauss, P.J. de Feyter, H. van Loon, R.J. van Suylen, H. Suryapranata, M.J. van den Brand, Histological features 3 to 320 days after stenting of human saphenous vein bypass grafts Journal of the American College of Cardiology. ,vol. 17, ,(1991) , 10.1016/0735-1097(91)91180-M
Jean-Jacques Goy, Ulrich Sigwart, Pierre Vogt, Jean-Christophe Stauffer, Lukas Kappenberger, Long-term clinical and angiographic follow-up of patients treated with the self-expanding coronary stent for acute occlusion during balloon angioplasty of the right coronary artery Journal of the American College of Cardiology. ,vol. 19, pp. 1593- 1596 ,(1992) , 10.1016/0735-1097(92)90623-U
G Dorros, M J Cowley, J Simpson, L G Bentivoglio, P C Block, M Bourassa, K Detre, A J Gosselin, A R Grüntzig, S F Kelsey, K M Kent, M B Mock, S M Mullin, R K Myler, E R Passamani, S H Stertzer, D O Williams, Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. ,vol. 67, pp. 723- 730 ,(1983) , 10.1161/01.CIR.67.4.723
G. Hafner, H. Swars, R. Erbel, W. Ehrenthal, H. J. Rupprecht, J. Lotz, J. Meyer, W. Prellwitz, Monitoring prothrombin fragment 1+2 during initiation of oral anticoagulant therapy after intracoronary stenting Annals of Hematology. ,vol. 65, pp. 83- 87 ,(1992) , 10.1007/BF01698135
Duncan A. Killen, William R. Hamaker, William A. Reed, Coronary Artery Bypass Following Percutaneous Transluminal Coronary Angioplasty The Annals of Thoracic Surgery. ,vol. 40, pp. 133- 138 ,(1985) , 10.1016/S0003-4975(10)60005-7